Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

Robert A Smith; Kimberly S Andrews; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Debbie Saslow; Otis W Brawley; Richard C Wender

doi:10.3322/caac.21392

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

CA Cancer J Clin. 2017 Mar;67(2):100-121. doi: 10.3322/caac.21392. Epub 2017 Feb 7.

Authors

Robert A Smith¹, Kimberly S Andrews², Durado Brooks³, Stacey A Fedewa⁴, Deana Manassaram-Baptiste², Debbie Saslow⁵, Otis W Brawley⁶, Richard C Wender⁷

Affiliations

¹ Vice President, Cancer Screening, Cancer Control Department, American Cancer Society, Atlanta, GA.
² Director, Cancer Control Department, American Cancer Society, Atlanta, GA.
³ Managing Director, Cancer Control Intervention, Cancer Control Department, American Cancer Society, Atlanta, GA.
⁴ Director for Risk Factor Screening and Surveillance, Department of Epidemiology and Research Surveillance, American Cancer Society, Atlanta, GA.
⁵ Senior Director, HPV Related and Women's Cancer, Cancer Control Department, American Cancer Society, Atlanta, GA.
⁶ Chief Medical Officer, American Cancer Society, Atlanta, GA.
⁷ Chief Cancer Control Officer, American Cancer Society, Atlanta, GA.

PMID: 28170086
DOI: 10.3322/caac.21392

Abstract

Answer questions and earn CME/CNE Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, the authors summarize current American Cancer Society cancer screening guidelines, describe an update of their guideline for using human papillomavirus vaccination for cancer prevention, describe updates in US Preventive Services Task Force recommendations for breast and colorectal cancer screening, discuss interim findings from the UK Collaborative Trial on Ovarian Cancer Screening, and provide the latest data on utilization of cancer screening from the National Health Interview Survey. CA Cancer J Clin 2017;67:100-121. © 2017 American Cancer Society.

Keywords: American Cancer Society; diagnosis; mass screening; neoplasms; prevention and control.

MeSH terms

American Cancer Society
Breast Neoplasms / diagnosis
Breast Neoplasms / prevention & control
Colonoscopy / standards
Colorectal Neoplasms / diagnosis
Colorectal Neoplasms / prevention & control
Early Detection of Cancer / adverse effects
Early Detection of Cancer / methods
Early Detection of Cancer / standards*
Endometrial Neoplasms / diagnosis
Endometrial Neoplasms / prevention & control
Female
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / prevention & control
Male
Mass Screening / adverse effects
Mass Screening / methods
Mass Screening / standards*
Ovarian Neoplasms / diagnosis
Ovarian Neoplasms / prevention & control
Papillomavirus Vaccines
Practice Guidelines as Topic
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / prevention & control
United States
Uterine Cervical Neoplasms / diagnosis
Uterine Cervical Neoplasms / prevention & control

Substances

Papillomavirus Vaccines